{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T13:38:49Z","timestamp":1788183529224,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100006520","name":"Edwards Lifesciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s12325-025-03116-8","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T08:08:59Z","timestamp":1739434139000},"page":"1716-1728","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["No-Transcatheter Aortic Valve Replacement (TAVR) Zones and Their Effect on Access to Care for Medicare Beneficiaries with Aortic Stenosis"],"prefix":"10.1007","volume":"42","author":[{"given":"Guy","family":"David","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Giri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin","family":"Nathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumya G.","family":"Chikermane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christin","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Clancy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0723-585X","authenticated-orcid":false,"given":"Candace","family":"Gunnarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"issue":"5","key":"3116_CR1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.5105","volume":"3","author":"J Tsui","year":"2020","unstructured":"Tsui J, Hirsch JA, Bayer FJ, et al. Patterns in geographic access to health care facilities across neighborhoods in the United States based on data from the national establishment time-series between 2000 and 2014. JAMA Netw Open. 2020;3(5):e205105. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.5105.","journal-title":"JAMA Netw Open"},{"issue":"suppl 1","key":"3116_CR2","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1111\/1475-6773.12736","volume":"53","author":"MR Daly","year":"2018","unstructured":"Daly MR, Mellor JM, Millones M. Do avoidable hospitalization rates among older adults differ by geographic access to primary care physicians? Health Serv Res. 2018;53(suppl 1):3245\u201364. https:\/\/doi.org\/10.1111\/1475-6773.12736.","journal-title":"Health Serv Res"},{"issue":"12","key":"3116_CR3","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1634\/theoncologist.2015-0110","volume":"20","author":"M Ambroggi","year":"2015","unstructured":"Ambroggi M, Biasini C, Del Giovane C, Fornari F, Cavanna L. Distance as a barrier to cancer diagnosis and treatment: review of the literature. Oncologist. 2015;20(12):1378\u201385. https:\/\/doi.org\/10.1634\/theoncologist.2015-0110.","journal-title":"Oncologist"},{"issue":"2","key":"3116_CR4","doi-asserted-by":"publisher","first-page":"65.e2","DOI":"10.1016\/j.annepidem.2017.11.012","volume":"28","author":"PI Jewett","year":"2018","unstructured":"Jewett PI, Gangnon RE, Elkin E, et al. Geographic access to mammography facilities and frequency of mammography screening. Ann Epidemiol. 2018;28(2):65.e2-71.e2. https:\/\/doi.org\/10.1016\/j.annepidem.2017.11.012.","journal-title":"Ann Epidemiol"},{"issue":"6","key":"3116_CR5","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.athoracsur.2015.05.058","volume":"100","author":"CL Cote","year":"2015","unstructured":"Cote CL, Singh S, Yip AM, et al. Increased distance from the tertiary cardiac center is associated with worse 30-day outcomes after cardiac operations. Ann Thorac Surg. 2015;100(6):2213\u20138. https:\/\/doi.org\/10.1016\/j.athoracsur.2015.05.058.","journal-title":"Ann Thorac Surg"},{"issue":"9","key":"3116_CR6","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1001\/jamacardio.2020.1725","volume":"5","author":"G Marquis-Gravel","year":"2020","unstructured":"Marquis-Gravel G, Stebbins A, Kosinksi AS, et al. Geographic access to transcatheter aortic valve replacement centers in the United States. JAMA Cardiol. 2020;5(9):1006\u201310. https:\/\/doi.org\/10.1001\/jamacardio.2020.1725.","journal-title":"JAMA Cardiol"},{"issue":"11","key":"3116_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-013059","volume":"6","author":"C Kelly","year":"2016","unstructured":"Kelly C, Hulme C, Farragher T, et al. Are differences in travel time or distance to healthcare for adults in global north countries associated with an impact on health outcomes? A systematic review. BMJ Open. 2016;6(11):e013059. https:\/\/doi.org\/10.1136\/bmjopen-2016-013059.","journal-title":"BMJ Open"},{"key":"3116_CR8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s13104-022-06117-w","volume":"15","author":"J Guo","year":"2022","unstructured":"Guo J, Hernandez I, Dickson S, et al. Income disparities in driving distance to health care infrastructure in the United States: a geographic information systems analysis. BMC Res Notes. 2022;15:225. https:\/\/doi.org\/10.1186\/s13104-022-06117-w.","journal-title":"BMC Res Notes"},{"issue":"2","key":"3116_CR9","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.030569","volume":"13","author":"G David","year":"2024","unstructured":"David G, Bergman A, Gunnarsson C, et al. Limited access to aortic valve procedures in socioeconomically disadvantaged areas. JAHA. 2024;13(2):e030569. https:\/\/doi.org\/10.1161\/JAHA.123.030569.","journal-title":"JAHA"},{"issue":"6","key":"3116_CR10","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1001\/jamacardio.2020.0443","volume":"5","author":"MP Thompson","year":"2020","unstructured":"Thompson MP, Brescia AA, Hou H, et al. Access to transcatheter aortic valve replacement under new Medicare surgical volume requirements. JAMA Cardiol. 2020;5(6):729\u201332. https:\/\/doi.org\/10.1001\/jamacardio.2020.0443.","journal-title":"JAMA Cardiol"},{"key":"3116_CR11","unstructured":"Transcatheter aortic valve replacement (TAVR) [Internet]. Washington (DC): Centers for Medicare and Medicaid Services. Available from: https:\/\/www.cms.gov\/medicare-coverage-database\/view\/ncacal-decision-memo.aspx?proposed=N&NCAId=293&type=Open&bc=ACAAAAAAQCAA&. Accessed June 2024."},{"key":"3116_CR12","unstructured":"Neighborhood Atlas [Internet]. Madison (WI): Center for Health Disparities Research. Available from: https:\/\/www.neighborhoodatlas.medicine.wisc.edu\/. Accessed  2024 Feb 21."},{"key":"3116_CR13","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41587-023-01746-3","volume":"41","author":"KT Kadakia","year":"2023","unstructured":"Kadakia KT, Rathi VK, Ramachandra R, et al. Challenges and solutions to advancing health equity with medical devices. Nat Biotechnol. 2023;41:607\u20139.","journal-title":"Nat Biotechnol"},{"issue":"5","key":"3116_CR14","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1007\/s10900-013-9681-1","volume":"38","author":"S Syed","year":"2013","unstructured":"Syed S, Gerber BS, Sharp LK. Traveling towards disease: transportation barriers to health care access. J Commun Health. 2013;38(5):976\u201393. https:\/\/doi.org\/10.1007\/s10900-013-9681-1.","journal-title":"J Commun Health"},{"key":"3116_CR15","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1177\/0361198105192400110","volume":"1924","author":"R Wallace","year":"2005","unstructured":"Wallace R, Hughes-Cromwick P, Mull H, et al. Access to health care and nonemergency medical transportation: two missing links. Transp Res Rec. 2005;1924:76\u201384.","journal-title":"Transp Res Rec"},{"issue":"2","key":"3116_CR16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.121.011489","volume":"15","author":"KP Reddy","year":"2022","unstructured":"Reddy KP, Groeneveld PW, Giri J, Fanaroff AC, Nathan AS. Economic considerations in access to transcatheter aortic valve replacement. Circ Cardiovasc Interv. 2022;15(2):e011489. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.121.011489.","journal-title":"Circ Cardiovasc Interv"},{"issue":"11","key":"3116_CR17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.121.008260","volume":"14","author":"AS Nathan","year":"2021","unstructured":"Nathan AS, Yang L, Yang N, et al. Socioeconomic and geographic characteristics of hospitals establishing transcatheter aortic valve replacement programs, 2012\u20132018. Circ Cardiovasc Qual Outcomes. 2021;14(11):e008260. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.121.008260.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"2","key":"3116_CR18","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1001\/jamacardio.2021.4641","volume":"7","author":"AS Nathan","year":"2022","unstructured":"Nathan AS, Yang L, Yang N, et al. Racial, ethnic, and socioeconomic disparities in access to transcatheter aortic valve replacement within major metropolitan areas. JAMA Cardiol. 2022;7(2):150\u20137. https:\/\/doi.org\/10.1001\/jamacardio.2021.4641.","journal-title":"JAMA Cardiol"},{"key":"3116_CR19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/ehjqcco\/qcz043","volume":"6","author":"S Bhattacharyya","year":"2020","unstructured":"Bhattacharyya S, Lloyd G. Mortality whilst waiting for intervention in symptomatic severe aortic stenosis. Eur Heart J Qual Care Clin Outcomes. 2020;6:89\u201390. https:\/\/doi.org\/10.1093\/ehjqcco\/qcz043.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"3116_CR20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.xjon.2021.06.006","volume":"7","author":"DR Freno","year":"2021","unstructured":"Freno DR, Shipe ME, Levack MM, et al. Modeling the impact of delaying transcatheter aortic valve replacement for the treatment of aortic stenosis in the era of COVID-19. JTCVS Open. 2021;7:63\u201371. https:\/\/doi.org\/10.1016\/j.xjon.2021.06.006.","journal-title":"JTCVS Open"},{"issue":"1","key":"3116_CR21","doi-asserted-by":"publisher","first-page":"5967","DOI":"10.1038\/s41598-022-09995-z","volume":"12","author":"V Roule","year":"2022","unstructured":"Roule V, Rebouh I, Lemaitre A, et al. Impact of wait times on late postprocedural mortality after successful transcatheter aortic valve replacement. Sci Rep. 2022;12(1):5967. https:\/\/doi.org\/10.1038\/s41598-022-09995-z.","journal-title":"Sci Rep"},{"key":"3116_CR22","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1161\/circulationaha.117.033432","volume":"138","author":"G Elbaz-Greener","year":"2018","unstructured":"Elbaz-Greener G, Masih S, Fang J, et al. Temporal trends and clinical consequences of wait times for transcatheter aortic valve replacement: a population-based study. Circulation. 2018;138:483\u201393. https:\/\/doi.org\/10.1161\/circulationaha.117.033432.","journal-title":"Circulation"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03116-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-025-03116-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03116-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T07:05:41Z","timestamp":1742713541000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-025-03116-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["3116"],"URL":"https:\/\/doi.org\/10.1007\/s12325-025-03116-8","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,13]]},"assertion":[{"value":"21 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report the following disclosures: Guy David, PhD is a consultant for Edwards Lifesciences. Andrew Epstein, PhD is an employee of Medicus Economics, which received funding from Edwards Lifesciences to conduct this research. Jay Giri, MD received research funding and served on advisory boards for Edwards Inc, Recor Medical, Inari Medical, Boston Scientific, and Biosense Webster and has equity in Endovascular Engineering. Ashwin Nathan, MD received speaker fees and institutional research funding from Abiomed, Biosense Webster and Edwards Lifesciences. Soumya G Chikermane, PhD is an employee of Edwards Lifesciences. Michael Ryan, MS is a consultant for Edwards Lifesciences. Christin Thompson, PhD is an employee of Edwards Lifesciences. Seth Clancy, MPH is an employee of Edwards Lifesciences. Candace Gunnarsson, EdD, MA is a consultant for Edwards Lifesciences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The WCG IRB determined that this research activity (#1-1709546-1) was exempt from IRB review under 45 CFR \u00a746.104(b)(4), because, although the research involves the use of identifiable private information, (1) that information is recorded by the investigator in such a manner that the identity of the human subjects cannot readily by ascertained directly or through identifiers linked to the subjects, (2) the investigator will not contact the subjects, and (3) the investigator will not re-identify subjects. WCG IRB also approved a full waiver of HIPAA authorization for use and disclosure of protected health information (PHI) based on adequate documentation that (1) the use or disclosure of the PHI involves no more than minimal risk to the individuals; (2) the research could not be practicably conducted without access to and use of the PHI; and (3) the research could not practicably be conducted without the waiver. This study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}